NEAT1 and glioma: In addition to PTC, the aberrant overexpression of NEAT1 was also observed in other types of cancer, such as glioma, hepatocellular carcinoma, and laryngeal cancer [16,17,26,27], and the oncogenic effects of NEAT1 on cancer cell proliferation, migration, and invasion were verified.